Sort
40,608 grants matching “prostate cancer”
Mechanism of epigenetic activation during disease progression
$838,796David Takeda · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy
$838,708Cohava Gelber · Serpin Pharma, Llc · R44 · FY2024 · CA
Identification of viral exposure signatures for early detection of liver cancer
$838,170Limin Wang · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices
$838,005Huma Q Rana · Dana-Farber Cancer Inst · R01 · FY2022 · HG
Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis
$837,856Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Biological Functions of Chromosomal Proteins
$837,688Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
MAP: a Flowable, Precision-Engineered, and Tunable Tissue Scaffold Leveraging Hyper-Porous Geometry to Control Inflammation and Promote Regenerative Healing in Diabetic Wounds
$836,914Stephanie Deshayes · Tempo Therapeutics, Inc. · R44 · FY2020 · DK
Prioritizing rare variants associated with cancer using non-coding annotation
$836,728Mark Bender Gerstein · Yale University · R01 · FY2016 · HG
Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study
$836,717Ken R Smith · University Of Utah · R01 · FY2012 · AG
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
$836,628Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2007 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center
$836,410Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
Nano Metal Enhanced Microarray
$836,089Svetlana Ivanovna Novikova · Microcosm, Inc. · R44 · FY2007 · CA
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$835,986Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2020 · CA
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
$835,947John Janik · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Prostate Cancer Studies
$835,899Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Clinical trials employing cancer vaccine combination therapies
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$835,822James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identification of human tumor-associated antigens
$835,772Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Enabling Technologies for MRI-Guided Prostate Interventions
$835,648Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2006 · CA
HEALTH DISPARITY IN AFRICAN AMERICANS: A META-ANALYSIS OF SIX PHASE III TRIALS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER MEN TREATED WITH DO
$835,601Duke University · · FY2015 · Department of the Army
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
$835,017Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MD
Elucidation of cancer pathways and druggable targets using mouse models.
$835,000Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2009 · CA
P3IK Signaling and Biology of Therapeutic Response in Brain and Prostate Tumors
$835,000Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2009 · CA
Radiation-induced translational control of gene expression
$834,513Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular Orgin Cancer--Catechol Estrogen 3 4 Quinones
$834,167University Of Nebraska Medical Center · P01 · FY2004 · CA